Last reviewed · How we verify
NCT07326267
School-Based Sensory Processing and Daily Living Skills-Focused Occupational Therapy Program
NA trial testing Individual School-Based Occupational Therapy Sessions in Intellectual Disability, Variable in 40 participants. Not yet recruiting.
1 March 2027
Quick facts
| Lead sponsor | Çankırı Karatekin University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 4 May 2026 |
| Primary completion | 1 March 2027 |
| Estimated completion | 1 March 2027 |
Drugs / interventions tested
- Individual School-Based Occupational Therapy Sessions
- Sensory Preparation Using Proprioceptive, Vestibular, and Tactile Input
- Task-Oriented Activities of Daily Living Training
- Generalization and Classroom-Based Sensory Support Strategies
- Family Education and Written Home Program
Conditions studied
- Intellectual Disability, Variable — all drugs for Intellectual Disability, Variable →
- Autism Spectrum Disorder (ASD) — all drugs for Autism Spectrum Disorder (ASD) →
Sponsor
Çankırı Karatekin University
Who can join
Adults 6 to 14, any sex, with Intellectual Disability, Variable or Autism Spectrum Disorder (ASD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop and evaluate a school-based occupational therapy program focused on sensory processing and activities of daily living for children with Autism Spectrum Disorder and Intellectual Disability. Sensory processing difficulties often affect school participation, behavior regulation, and independence in daily tasks. Although occupational therapy interventions have shown benefits in clinical settings, evidence for their use in schools is limited. The trial will take place at Vali Ayhan Çevik Special Education School and will enroll students aged 6 to 14 years. Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive weekly 50-minute occupational therapy sessions for 10 to 12 weeks, including sensory preparation, task-oriented practice, and strategies to support everyday skills. The control group will receive family education, a written home program, and routine school observation. Outcomes will be assessed at baseline, after the intervention, and at 4 to 6-week follow-up. The main outcome is change in Goal Attainment Scaling scores, which reflect progress toward individualized goals. Additional measures include functional ability, sensory processing, and demographic and clinical information. The study will also monitor feasibility and how closely the program is delivered as planned. This research is expected to provide evidence on the feasibility and effects of a standardized occupational therapy program in a school setting and to support the use of similar approaches in educational contexts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07326267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Çankırı Karatekin University trials
Trials by the same sponsor.
- NCT07512544 — Building Sustainability Competencies in Future Nurses · NA · not yet recruiting
- NCT07266870 — Effect of CORE on Knowledge and Attitude Levels Regarding Pain Assessment · NA · completed
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT07207655 — Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV) · NA · not yet recruiting
- NCT07061743 — Activity Management Training in Low Back Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07326267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çankırı Karatekin University
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07326267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing